Skip to main content

and
  1. Article

    Open Access

    Expression of NRG1 and its receptors in human bladder cancer

    Therapies targeting ERBB2 have shown success in the clinic. However, response is not determined solely by expression of ERBB2. Levels of ERBB3, its preferred heterodimerisation partner and ERBB ligands may als...

    J A Forster, A B Paul, P Harnden, M A Knowles in British Journal of Cancer (2011)

  2. Article

    Open Access

    Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein

    Validated objective biomarkers are needed for patients with renal cell carcinoma (RCC) to guide patient management and define high-risk populations for follow-up or for therapeutic purposes.

    S P K Jagdev, W Gregory, N S Vasudev, P Harnden, S Sim in British Journal of Cancer (2010)

  3. No Access

    Chapter and Conference Paper

    Detection of Glycosylation Changes in Serum and Tissue Proteins in Cancer by Lectin Blotting

    R. E. Ferguson, D. H. Jackson, R. Hutson, N. Wilkinson in Glycobiology and Medicine (2005)

  4. Article

    Open Access

    Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancer

    Reduced expression of the adhesion molecule E-cadherin has been associated with increased invasiveness and poorer survival in patients with bladder cancer. We have examined soluble E-cadherin (sE-cadherin) and...

    A S Protheroe, R E Banks, M Mzimba, W H Porter, J Southgate in British Journal of Cancer (1999)

  5. No Access

    Article

    Muscle hypertrophy in Duchenne muscular dystrophy

    In order to investigate the pathological basis of muscle hypertrophy in Duchenne dystrophy, 9 biopsy specimens of the lateral gastrocnemius and 7 of the vastus lateralis were compared. All patients had calf hy...

    D. Cros, P. Harnden, J. F. Pellissier, G. Serratrice in Journal of Neurology (1989)